Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLYMPUS: Povetacicept vs Tacrolimus in Primary Membranous Nephropathy
NCT07204275Phase 3Recruiting
- Sponsor
- Vertex Pharmaceuticals
- Start
- Sep 2025
- Primary completion
- Dec 2028
- Modality
- Antibody Fragments, Fc-Fusion Proteins
- Countries
- 14
01
Overview
A Phase 3 trial of povetacicept in primary membranous nephropathy (PMN), sponsored by Vertex Pharmaceuticals. Started Sep 2025; status: recruiting.
02
Drugs
povetacicept
03
Conditions
primary membranous nephropathy (PMN)
Beyond the preview
Go deeper on NCT07204275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07204275.